imipenem, anhydrous has been researched along with Adenocarcinoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiang, YR; Chung, FH; Huang, MC; Lee, HC; Lu, J; Ma, N; Sung, YC; Tseng, AL | 1 |
| Hara, N; Hiratsuka, M; Ichikawa, Y; Ishibashi, T; Kido, M; Kondo, Y; Kuroki, S; Kusano, T; Mitsuyama, T; Miyahara, T; Motohiro, A; Nakanishi, Y; Naoe, H; Nikaido, Y; Ninomiya, K; Ohno, T; Oizumi, K; Senju, S; Shigematsu, H; Takamoto, M; Tanaka, H; Ueda, H; Watanabe, K; Yamada, H; Yoshida, M | 1 |
| Eidelberg, D; Frucht, S | 1 |
| Barbarini, D; Carretto, E; Emmi, V; Marone, P; Marzani, FC; Poletti, F | 1 |
| Khalimov, ID; Krasin, VV; Latypov, AG; Potanin, AV; Potanin, VP; Sigal, EI; Sigal, RI; Taziev, RM | 1 |
| Ina, Y; Kakihara, H; Morishita, M; Noda, M; Senda, Y; Sugiura, T; Takada, K; Torii, Y; Yamamoto, M; Yoshikawa, K | 1 |
2 trial(s) available for imipenem, anhydrous and Adenocarcinoma
| Article | Year |
|---|---|
[Clinical efficacy of imipenem/cilastatin sodium for respiratory infections in patients with lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Opportunistic Infections; Respiratory Tract Infections | 1997 |
[Therapeutic efficacy of imipenem/cilastatin sodium on respiratory tract infections in lung cancer patients].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bacteria; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Lung Neoplasms; Male; Middle Aged; Respiratory Tract Infections | 1991 |
4 other study(ies) available for imipenem, anhydrous and Adenocarcinoma
| Article | Year |
|---|---|
Functional Module Connectivity Map (FMCM): a framework for searching repurposed drug compounds for systems treatment of cancer and an application to colorectal adenocarcinoma.
Topics: Adenocarcinoma; Algorithms; Colorectal Neoplasms; Drug Repositioning; Epistasis, Genetic; Ethacrynic Acid; Gene Regulatory Networks; Ginkgolides; Humans; Imipenem; Indoles; Lactones; Microarray Analysis; Phenoxybenzamine; Sensitivity and Specificity; Thymine | 2014 |
Imipenem-induced myoclonus.
Topics: Adenocarcinoma; Arm; Female; Humans; Imipenem; Middle Aged; Myoclonus; Ovarian Neoplasms; Thienamycins | 1997 |
Bacillus cereus fatal bacteremia and apparent association with nosocomial transmission in an intensive care unit.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Bacillus cereus; Bacteremia; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Fatal Outcome; Female; Humans; Imipenem; Intensive Care Units; Lung Neoplasms; Microbial Sensitivity Tests; Middle Aged; Thienamycins; Vancomycin | 2000 |
[Thienam treatment in early postoperative period after pneumonectomy in patients with lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Postoperative Care; Postoperative Complications; Time Factors | 2001 |